I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

Merck is expanding in oncology, immunology, and vaccines through acquisitions and R&D. Find out what makes MRK a stable GARP ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...

We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Moderna ...

Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world needed it the most. However, the stock has largely struggled since the pandemic ...

A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...

We recently published a list of These 10 Firms Just Beat the Market Today. In this article, we are going to take a look at ...

Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...